Allogene Therapeutics Reports Second Quarter 2019 Financial Results

Go back to Allogene Therapeutics Reports Second Quarter 2019 Financial Results
(NASDAQ: ALLO) Delayed: 2.15 -0.08 (3.59%)
Previous Close $2.23    52 Week High
Open $2.19    52 Week Low
Day High $2.21    P/E N/A 
Day Low $2.14    EPS
Volume 574,576